EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C47H77N3O36R2 |
| Net Charge | 0 |
| Average Mass (excl. R groups) | 1260.115 |
| Monoisotopic Mass (excl. R groups) | 1259.42868 |
| SMILES | [1*][C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O[C@]6(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@]([H])([C@H](O)[C@H](O)CO)O6)[C@H]5O)[C@H]4NC(C)=O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC([2*])=O |
| Roles Classification |
|---|
| Biological Role: | tumour antigen An antigenic substance produced in tumour cells, which triggers an immune response in the host. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| α-Neu5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer (CHEBI:189546) has role tumour antigen (CHEBI:144829) |
| α-Neu5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer (CHEBI:189546) is a globoside (CHEBI:61360) |
| α-Neu5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer (CHEBI:189546) is a glycohexaosylceramide (CHEBI:36642) |
| α-Neu5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer (CHEBI:189546) is conjugate acid of Monosialyl-Gb5(1−) (CHEBI:140623) |
| Incoming Relation(s) |
| Monosialyl-Gb5(1−) (CHEBI:140623) is conjugate base of α-Neu5Ac-(2→3)-β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer (CHEBI:189546) |
| Synonyms | Source |
|---|---|
| SSEA-4 | MetaCyc |
| stage-specific embryonic antigen 4 | ChEBI |
| SSEA-4 antigen | LIPID MAPS |
| NeuAcα2-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer | LIPID MAPS |
| SSEA4 | MetaCyc |
| NeuAcα2→3Galβ1→3GalNAcβ1→3Galα1→4Galβ1→4Glcβ1→1Cer | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| SSEA4 | MetaCyc |
| LMSP0601AB00 | LIPID MAPS |
| G00098 | KEGG GLYCAN |
| Citations |
|---|